US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

216.40

+3.871.82%

Post-market: 216.00-0.4000-0.18%19:59 EDT

Volume:1.47M

Turnover:316.80M

Market Cap:10.88B

PE:34.28

High:217.12

Open:213.40

Low:213.22

Close:212.53

52wk High:217.12

52wk Low:137.09

Shares:50.30M

Float Shares:50.30M

Volume Ratio:0.69

T/O Rate:2.91%

Dividend:0.40

Dividend Rate:0.19%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.34

PE(LYR):-144.85

Loading ...

Overview Company News Filings

Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray

How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock

Henlius Shares Surge Nearly 8% on Strategic Alliance with Sandoz for Up to Ten Biosimilars

Arovella lodges 2026 corporate governance statement and Appendix 4G

ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Regeneron Announces Investor Conference Presentations

Marvel Biosciences Extends Private Placement Access to Quebec Investors

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

US FDA Approves Regeneron's Rare Bone Disorder Drug

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/IBB/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":216.4,"timestamp":1787688000000,"preClose":212.53,"halted":0,"volume":1466169,"hourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"delay":0,"changeRate":0.018209193996141744,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"Closed","change":3.87,"latestTime":"08-25 16:00:00 EDT","open":213.4,"high":217.12,"low":213.22,"amount":316799197.11812997,"amplitude":0.01835,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":212.53,"sharesOutstanding":49450000,"nav":212.515646,"aum":10647033864.6,"dividendRate":0.001866,"bidAskSpread":0.000376,"preHourTrading":{"tag":"盘前","latestPrice":213.19,"preClose":212.53,"latestTime":"09:29 EDT","volume":272,"amount":58020.02352,"timestamp":1787664595037,"change":0.66,"changeRate":0.003105,"amplitude":0.007293},"postHourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"volumeRatio":0.68846,"impliedVol":0.2594,"impliedVolPercentile":0.8566},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.68846,"shares":50300000,"dividePrice":0.4038,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.88","week52High":217.12,"institutionHeld":0,"latestPrice":216.4,"eps":6.311863,"divideRate":0.001866,"volume":1466169,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660028408","title":"Glenmark Wins U.S. FDA Nod for Generic Flonase Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028408","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:43","pubTimestamp":1787200984,"startTime":"0","endTime":"0","summary":"Glenmark Pharmaceuticals Limited ( ($IN:GLENMARK) ) just unveiled an announcement. Glenmark Pharmaceuticals has secured U.S. FDA approval for its F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glenmark-wins-u-s-fda-nod-for-generic-flonase-nasal-spray?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","IDNA","PSCH","RSPH","TBXU","BMED","XLVX","MRNX","BBP","PINK","IEIH","SYNB","TECB","BK4588","LFSC","MRNY","GDOC","BK4585","GNMX","LABU","IYH","FRTY","IBB","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193854306","title":"How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1193854306","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193854306?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:40","pubTimestamp":1787197200,"startTime":"0","endTime":"0","summary":"A customized vaccine from Merck and Moderna kept melanoma patients cancer-free for longer than standard treatments in a Phase 3 trial.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","MRNA","MRNX","MRNY","IBB","NVAX","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191429118","title":"Henlius Shares Surge Nearly 8% on Strategic Alliance with Sandoz for Up to Ten Biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=1191429118","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191429118?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:00","pubTimestamp":1787194818,"startTime":"0","endTime":"0","summary":"Shares of HENLIUS (02696) climbed nearly 8% during intraday trading, with the stock last up 6.87% at HK$70.05, recording a turnover of HK$16.47 million. The company recently announced a framework...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000306685.HKD","HK0000320223.HKD","LU2473716301.USD","LU2322448957.HKD","LU2272731865.HKD","LU2322448791.USD","XPH","HK0000165453.HKD","BK4588","PPH","HK0000306701.USD","BK4585","HK0000320264.USD","LU2272731782.SGD","IE00B5TLWC47.USD","LU1992135472.HKD","LU2272731600.USD","IBB","BK1161","LU1992135399.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660921472","title":"Arovella lodges 2026 corporate governance statement and Appendix 4G","url":"https://stock-news.laohu8.com/highlight/detail?id=2660921472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660921472?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:37","pubTimestamp":1787189875,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an announcement. Arovella Therapeutics Limited, an ASX-listed biotechnology company, undersc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arovella-lodges-2026-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arovella-lodges-2026-corporate-governance-statement-and-appendix-4g?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","ALA","IEIH","HAPY","JDOC","ESGV","SSPX","CDEI","ESML","NUSC","NUDV","FDRX","ESGY","DARP","CHRI","RSPH","FWD","AGNG","BK4585","VOTE","XT","DSI","CVLC","MDCP","JSTC","BK4588","SUSA","FHLC","ESGA","LOPP","HAPI","LNGR","SYNB","EXEQ","BBP","ESG","PEMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193034377","title":"ETF Daily | MRNX Soars 352%; MRNY Surges 169%; TEMC, TEMT Jump 48%; NUGT Climbs 18%; Gold Miners and Biotech Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1193034377","media":"ETF Tracker","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193034377?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:33","pubTimestamp":1787186013,"startTime":"0","endTime":"0","summary":"Market OverviewOn Wednesday Aug 19, the Dow Jones Industrial Average added 0.22%, the S&P 500 rose 0.21%, and the Nasdaq Composite edged up 0.16%.ETF market breadth was constructive, with gains...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e426da9b0703426f963fa150b0854bd3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDXD","MSTY","MSTP","TSYW","XPP","SG9999014039.USD","BK4535","BK4581","3SMI.UK","BK4533","LGHT","SHV","WNTR","02843","FLGV","KGLD","MSOO","CQQQ","DGP","WYFI","WYFL","GNT","BK4023","FGDL","FWD","APED","GLDY","OWNB","IE00BN0W2W23.USD","BK7062","82823","SGOL","07799","EDC","GDX.AU","82822","IE00BQXX3F31.USD","GNOM","LMI3.UK","TLT","09799","TEMT","BEGS","TLH","GBUG","GDXU","MCHI","AGQ","IDNA","MSTW","BBLB","RING","EWY","ZSL","PUR","DZZ","IAUI","AEHG","FLCH","IE00BQXX3D17.EUR","LVIG","MSDD","XME","LU2095319765.USD","CRPT","BK4585","MSST","YANG","USG","BK4139","ASHR","BAR","MSTZ","LU0314104364.USD","ARKY","GLDM","SPTL","SOXS","BK4516","DBB","VCLT","BK4614","IBB","ITB","SHY","BK4548","YINN","IE00B64PRP62.GBP","02822","BK4551","AAAU","TBJL","MST","SMST","MRNY","GOLY","SHNY","IGLD","07399","DUST","TUR","SG9999014005.SGD","MSTK","ASHS","MSTR","IGOV","3LMI.UK","BK4600","UYM","IE00BQXX3C00.GBP","BK4147","BGLD","CWEB","GUNR","TLTW","BWZ","BK4550","OUNZ","SPLB","LU2210150020.SGD","BTGD","MSTX","IE00B3QW5Z07.USD","YXI","MRNX","BK4501","BK4595","GDMN","SG9999014013.SGD","GLTR","PICK","UGL","SGOV","XLV","BK4568","FXI","BK7095","BK4596","DBC","BK4112","MTYY","02840","BCDF","GLL","KWEB","YGLD","BITQ","CEF","LAZR","GDXJ","TEMC","FDN","IE00BKPKM429.USD","BK4563","CHAU","NUGT","LABU","PHYS","SGDM","09399","SIVR","IE00BGHQF748.EUR","LU2210149790.SGD","TEM","DGZ","BBSB","DULL","JDST","82843","FXP","GDXY","IE00BN0W2V16.EUR","BERZ","BBIB","BK4534","MSTR.AU","DRAG","SMI3.UK","GOAU","IAU","TLTX","PPI","TLTI","IE00BN0W2T93.GBP","TFJL","WDNA","JNUG","MRNA","02823","BK4207","BK4532","IMST","GLD","IEF","BK4588","IEI","XBI","MSTU","GDX","SLV","MSII","SOXL","ISHG","SG9999014021.USD","FEMB","BWX","IAUM","AEHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0889565916.HKD","IDNA","IBB","IE0002141913.USD","LU0566484027.USD","GNMX","VRTX","LU2462157665.USD","BK4588","LU0320765992.SGD","SG9999013999.USD","VERX","LU2362541513.USD","SGXZ57979304.SGD","PBE","LU0234570918.USD","LU1093756168.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","LU0061475181.USD","BK4533","LU0058720904.USD","IE00BZ9MQY76.HKD","SG9999001176.SGD","IBBQ","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","BK4585","IE0009355771.USD","TBXU","IE00BJT1NW94.SGD","LU2456880835.USD","IE0002270589.USD","LU1035775433.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","LU2236285917.USD","SG9999001176.USD","LU1093756325.SGD","BK4023","IE00B19Z9P08.USD","BBH","BIB","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479247","title":"Telix outlines H1 2026 progress in radiopharmaceutical and precision medicine units","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479247?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182181,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals released an interim H1 2026 results presentation outlining...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-outlines-h1-2026-progress-in-radiopharmaceutical-and-precision-medicine-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FDIF","TLX","GNOM","IDNA","LFSC","XT","TMAT","WDNA","BK4139","BMED","PBE","HELX","GNMX","SYNB","GDOC","IBB","MEDX","JDOC","BK4588","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660796854","title":"Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660796854","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660796854?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:10","pubTimestamp":1787181028,"startTime":"0","endTime":"0","summary":"Telix swings to H1 FY26 net profit of US$38 million; revenue rises 22% to US$477 millionTelix Pharmaceuticals reported H1 2026 revenue of US$477 million, up 22% year over year.Net profit swung to US$3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLbYKwmX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823434583.USD","LU0320765992.SGD","LU0109394709.USD","LU2362541273.HKD","IBB","BK4585","LU2362540622.SGD","TBXU","LU0823434740.USD","LU0823416689.USD","BK4139","REGN","BK4588","LU0058720904.USD","LU2362541513.USD","LU1974910355.USD","LU2023250504.SGD","BBH","LU0882574055.USD","LU0053666078.USD","BK7067","LU2106854487.HKD","LU2089984988.USD","LU0889565916.HKD","TLX.AU","IBBQ","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","IE00B19Z3581.USD","BK4139","BK4588","LU0061475181.USD","LU1035775433.USD","SPHQ","IE00B4R5TH58.HKD","LU1674673428.USD","VERX","BK4533","LU2089984988.USD","IDNA","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B19Z9Z06.USD","LU2468319806.SGD","VRTX","SG9999013999.USD","LU0320765992.SGD","LU0256863811.USD","IBBQ","LU1069344957.HKD","LU2462157665.USD","IE00B2B36J28.USD","TBXU","SG9999001176.SGD","LU0566484027.USD","PBE","IE00BJT1NW94.SGD","IE00B894F039.SGD","LU0432979614.USD","IBB","LU0889565916.HKD","GNMX","LU0058720904.USD","LU2456880835.USD","BK4532","LU1815336091.USD","LU0417517546.SGD","LU0757428866.USD","BBH","LU0823416689.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","BIB","LU0109394709.USD","SG9999001176.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU0432979614.USD","IE00B19Z9P08.USD","BK4139","IE00B19Z3581.USD","LU1674673691.USD","PBE","SGXZ57979304.SGD","IBB","LU0289739699.SGD","LU2089984988.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","TBXU","IE00B894F039.SGD","IE0002141913.USD","BIB","IBBQ","IE00B2B36J28.USD","LU2417539215.USD","LU2362541513.USD","BBH","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU1815336091.USD","BK4585","IDNA","LU1035775433.USD","IE00B19Z9Z06.USD","SG9999001176.SGD","LU2324357040.USD","LU2456880835.USD","LU1585245621.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","LU2462157665.USD","BK4567","LU1093756168.USD","VERX","BK4588","BK4533","LU0566484027.USD","LU0234570918.USD","LU1069344957.HKD","SG9999001176.USD","GNMX","VRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNX","GILD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","BK4583","MRNY","LU1934455863.HKD","IE00B19Z3B42.SGD","IBBQ","MEDI","BK4588","SG9999015978.USD","LU0320765992.SGD","LU0861579265.USD","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD","LU1430594728.SGD","LU0889565916.HKD","SG9999015952.SGD","BK4548","LU0289739699.SGD","LU2324357040.USD","LU0234570918.USD","LU1934455194.USD","LU0965509010.AUD","BK4139","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1585245621.USD","MRNA","BBH","LU0965509283.SGD","LU1934455277.USD","IBB","IDNA","LGHT","LU0122379950.USD","BMED","BK4578","GNOM","TBXU","TMED","LU1778281490.HKD","WDNA","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473673","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473673","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473673?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170546,"startTime":"0","endTime":"0","summary":"• Vertex stock surged to record highs following a rival's clinical trial failure.\n• Q2 revenue beat estimates, and the company raised its full-year guidance.\n• Analysts issued bullish ratings with an average price target of $563.25.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119122-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2362541513.USD","PBE","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2324357040.USD","IE00B894F039.SGD","SG9999001176.USD","BK4585","TBXU","LU1674673691.USD","BK4567","LU0889565916.HKD","LU1093756325.SGD","BBH","IBBQ","IE00BZ9MQY76.HKD","LU0061475181.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","LU2417539215.USD","IE00B19Z3B42.SGD","BIB","VRTX","IE00B19Z3581.USD","LU0823416689.USD","LU2237438978.USD","LU2362541273.HKD","IE0002270589.USD","LU2462157665.USD","LU2362540622.SGD","IDNA","LU1585245621.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1035775433.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","BK4533","IE00B2B36J28.USD","LU1778281490.HKD","LU0417517546.SGD","LU2456880835.USD","BK4532","BK4588","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","GNMX","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU0289739699.SGD","LU0058720904.USD","LU1069344957.HKD","LU1093756168.USD","LU0079474960.USD","SG9999001176.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU0289739699.SGD","LU2468319806.SGD","IE00BQXX3C00.GBP","BCDF","LU0114720955.EUR","LU0823434583.USD","LU0320765992.SGD","LU0109394709.USD","IE00BN0W2T93.GBP","IBB","LU2362541273.HKD","LU0314104364.USD","SG9999014039.USD","BK4585","LU2362540622.SGD","TBXU","LU2210149790.SGD","LU0823434740.USD","LU0823416689.USD","BK4139","REGN","IE00BN0W2V16.EUR","BK4112","BK4588","LU0058720904.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BQXX3D17.EUR","LU2362541513.USD","LU1974910355.USD","LU2023250504.SGD","IE00B3QW5Z07.USD","BBH","IE00BKPKM429.USD","LU0882574055.USD","LU2095319765.USD","LU0053666078.USD","LU2106854487.HKD","NDAQ","SG9999014005.SGD","LU2089984988.USD","LU0889565916.HKD","IE00BGHQF748.EUR","IBBQ","LU2210150020.SGD","LU1917777945.USD","LU2237438978.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU2468319806.SGD","LU0320765992.SGD","LU2362540622.SGD","LU0289739699.SGD","IBBQ","TBXU","LU1974910355.USD","LU2237438978.USD","LU0109394709.USD","LU0889565916.HKD","BK4585","LU2089984988.USD","LU0823434583.USD","LU0823434740.USD","REGN","BK4139","LU2023250504.SGD","LU1917777945.USD","LU0053666078.USD","BBH","BK4588","IBB","LU0058720904.USD","LU0823416689.USD","LU0882574055.USD","LU2106854487.HKD","LU2362541513.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747836","title":"Marvel Biosciences Extends Private Placement Access to Quebec Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747836?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:08","pubTimestamp":1787166508,"startTime":"0","endTime":"0","summary":"Marvel Biosciences Corp ( ($TSE:MRVL) ) has provided an announcement. Marvel Biosciences Corp. is a Calgary-based pre-clinical biotechnology compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-extends-private-placement-access-to-quebec-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","DARP","IEIH","IBB","RSPH","FHLC","BK4585","LNGR","AGNG","BK4588","XT","JDOC","SYNB","ISBC","BBP","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","LU0882574055.USD","LU1974910355.USD","LU0289739699.SGD","BK4585","LU0114720955.EUR","LU0889565916.HKD","BBH","LU0058720904.USD","REGN","LU2362541273.HKD","LU0053666078.USD","LU2468319806.SGD","LABU","LU1917777945.USD","LU0109394709.USD","LU2023250504.SGD","LU0823434740.USD","LU0823416689.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541513.USD","LU0823434583.USD","BK4588","IBBQ","LU2089984988.USD","LU0320765992.SGD","TBXU","BK4139","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420810","title":"Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420810","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420810?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:15","pubTimestamp":1787163346,"startTime":"0","endTime":"0","summary":"• Argus raised Amgen's price target and reiterated a Buy rating.\n• Second-quarter financial performance exceeded Wall Street revenue and earnings expectations.\n• Technical indicators show a MACD buy signal and RSI buy condition.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118745-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU1057294990.SGD","LU2468319806.SGD","BK4581","IE00B2B36J28.USD","LU2242652126.USD","TBXU","IBB","LU2242646821.SGD","IE0002141913.USD","BK4534","LU0289739699.SGD","BK4533","LU0320765992.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","04332","BK4588","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","LU2089984988.USD","BIB","PJP","LU0868494617.USD","LU1983299246.USD","LU1061106388.HKD","PBE","BK4139","BK4599","IE0009355771.USD","LU0109394709.USD","LU2112291526.USD","AMGN","IBBQ","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0889565916.HKD","BK4566","BBH","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660272694","title":"US FDA Approves Regeneron's Rare Bone Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660272694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660272694?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162562,"startTime":"0","endTime":"0","summary":"US FDA approves Regeneron's rare bone disorder drugAug 19-The U.S. Food and Drug Administration on Wednesday approved Regeneron'sREGN.Oexperimental treatment fora rare genetic disorder after the drug significantly reduced abnormal bone formation in certain soft tissues.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBBQ","LU1974910355.USD","LU0320765992.SGD","REGN","TBXU","LU2362541513.USD","LU0889565916.HKD","LU2023250504.SGD","LU2237438978.USD","LU2468319806.SGD","LU1917777945.USD","BK4588","BK4585","LU0823434583.USD","LU0882574055.USD","LU2106854487.HKD","LU2089984988.USD","LU0289739699.SGD","LU0053666078.USD","LU2362540622.SGD","LU0823416689.USD","LU0823434740.USD","LU0058720904.USD","LU2362541273.HKD","LU0114720955.EUR","IBB","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","LU0823434583.USD","LU2362541513.USD","LU0109394709.USD","IBB","REGN","BK4139","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","LU0320765992.SGD","IBBQ","BK4585","BK4588","LU0289739699.SGD","LU2362540622.SGD","LU0114720955.EUR","LU2362541273.HKD","LU2468319806.SGD","LU1974910355.USD","LU0053666078.USD","LU0058720904.USD","BBH","LU2237438978.USD","TBXU","LU2106854487.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1974910355.USD","LU0109394709.USD","IBB","BK4139","LU2106854487.HKD","LU0058720904.USD","LU0823416689.USD","LU0823434740.USD","LU2362541273.HKD","LU0889565916.HKD","LU1917777945.USD","LU2023250504.SGD","LU0882574055.USD","BBH","LU2362541513.USD","BK4585","BK4588","LU0053666078.USD","LU2237438978.USD","REGN","LU0289739699.SGD","LU0823434583.USD","LU0114720955.EUR","TBXU","LU2362540622.SGD","LU2468319806.SGD","IBBQ","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}